Risk Management Plans (RMP/REMS)

PVCON provides expert Risk Management Plan (RMP) and REMS development services that meet the requirements of the EMA, FDA, and global regulatory authorities. Our medical writers and pharmacovigilance specialists collaborate to produce comprehensive risk management documents that define safety specifications, pharmacovigilance plans, and risk minimization measures for your medicinal products.

Our services cover the complete RMP lifecycle — from initial development during clinical development through post-authorization updates triggered by new safety data, regulatory requests, or periodic renewal. We also develop FDA Risk Evaluation and Mitigation Strategies (REMS) including ETASU elements, medication guides, and communication plans as required.

PVCON supports organizations with risk minimization strategy planning, additional risk minimization measures design, effectiveness evaluation frameworks, and ongoing safety surveillance integration. Our RMP documents are crafted with scientific rigor and regulatory precision, ensuring successful submissions and efficient regulatory review cycles across all target markets.